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ABSTRACT
Introduction In the field of arthroscopic rotator cuff repair 
(ARCR), reporting standards of published studies differ 
dramatically, notably concerning adverse events (AEs). In 
addition, prognostic studies are overall methodologically 
poor, based on small data sets and explore only limited 
numbers of influencing factors. We aim to develop 
prognostic models for individual ARCR patients, primarily 
for the patient- reported assessment of shoulder function 
(Oxford Shoulder Score (OSS)) and the occurrence of 
shoulder stiffness 6 months after surgery. We also aim to 
evaluate the use of a consensus core event set (CES) for 
AEs and validate a severity classification for these events, 
considering the patient’s perspective.
Methods and analysis A cohort of 970 primary ARCR 
patients will be prospectively documented from several 
Swiss and German orthopaedic clinics up to 24 months 
postoperatively. Patient clinical examinations at 6 and 
12 months will include shoulder range of motion and 
strength (Constant Score). Tendon repair integrity status 
will be assessed by ultrasound at 12 months. Patient- 
reported questionnaires at 6, 12 and 24 months will 
determine functional scores (subjective shoulder value, 
OSS), anxiety and depression scores, working status, 
sports activities, and quality of life (European Quality of 
Life 5 Dimensions 5 Level questionnaire). AEs will be 
documented according to a CES. Prognostic models will be 
developed using an internationally supported regression 
methodology. Multiple prognostic factors, including patient 
baseline demographics, psychological, socioeconomic and 
clinical factors, rotator cuff integrity, concomitant local 
findings, and (post)operative management factors, will be 
investigated.
Ethics and dissemination This project contributes to 
the development of personalised risk predictions for 
supporting the surgical decision process in ARCR. The 
consensus CES may become an international reference 
for the reporting of complications in clinical studies and 
registries. Ethical approval was obtained on 1 April 2020 
from the lead ethics committee (EKNZ, Basel, Switzerland; 
ID: 2019-02076). All participants will provide informed 
written consent before enrolment in the study.
Trial registration number NCT04321005.
Protocol version Version 2 (13 December 2019).
INTRODUCTION
Rotator cuff tears are one of the most 
common injuries of the shoulder joint, which 
may cause pain and disability associated with 
severe restrictions in daily activities. Surgical 
repair is indicated when non- operative treat-
ment fails or follows extended traumatic 
tears, notably inactive patients without 
signs of advanced tendon degeneration or 
muscle fat infiltration.1 Clinical studies have 
demonstrated clinically relevant improve-
ment in shoulder function and quality of 
life after arthroscopic rotator cuff repair 
(ARCR).2–5 The number of ARCRs has 
increased over the last two decades6–9 due 
to several contributing factors, such as an 
ageing yet active population, improvements 
Strengths and limitations of this study
 ► This is a large prospective multicentre observation 
of routine care.
 ► The study is an assessment of patient- reported 
outcomes.
 ► The study will implement an international core out-
come set of adverse events.
 ► The study will use internationally supported meth-
odology for prognostic model development.
 ► There is potential limited response to patient ques-
tionnaires at 24 months.
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in operative repair techniques and more liberal indica-
tions for ARCRs.
Not all patients, however, benefit from ARCR.10 Patients 
may be affected by complications and/or adverse events 
(AEs) such as persistent pain, shoulder stiffness, infection, 
neurological problems and repair failures.11 12 About 20% 
of patients may show, typically between 6 and 12 months 
following ARCR, a persistent rotator cuff defect.13 Patients 
with healed tendons may show better functional outcome 
after repair.2 14 15 Postoperative shoulder stiffness, a 
major complication reported to occur in 1.5%–11.1% 
of ARCRs,11 leads to limitations in everyday activities, 
prolonged rehabilitation, and in severe cases to reoper-
ation (capsular release).16–18 Nonetheless, incident data 
on outcome and AEs are impaired by the heterogeneity 
in definition and reporting.13 19
Valid and representative data on the safety and effec-
tiveness of ARCR are non- existent at the Swiss national 
level. However, such data are paramount for optimising 
the indication and outcome of ARCR and for bench-
marking orthopaedic clinics. Reporting standards are a 
prerequisite for outcome and safety data. Recently, a core 
outcome set (COS)20 was defined for shoulder disorders, 
which includes inner core domains of pain, physical func-
tion and activities, global perceived effect (a person’s 
assessment of their recovery or degree of improvement), 
and AEs.21 22 A core event set (CES) was developed by 
international consensus in ARCR12 23 and lay the ground 
for the current project.
Appropriate indication of ARCR and judgement on 
risks of AEs or unsatisfactory patient outcomes rely on 
validated clinical prediction tools,24 25 which are still 
sparse in the field of surgical repair of a rotator cuff tear. 
Currently existing models focus on early surgical repair,26 
tendon healing27 28 or shoulder functional outcomes.29 
A model for shoulder stiffness included patients with 
various shoulder pathologies and surgeries.30 Further-
more, individual outcome predictions in ARCR require 
the identification of relevant patient and management 
factors. Several systematic reviews have highlighted the 
general lack of qualitative studies focused on prognostic 
factors for ARCR outcomes.31–35 In addition, we have 
observed substantial heterogeneity in terms of applied 
methodology, core outcomes and studied prognostic 
factors, where certain factors (eg, age, tear size, muscle 
degeneration, smoking) are given greater focus over 
others (eg, sex, traumatic onset). The reviews highlight 
the need for more robust prospective studies to include 
additional patient- reported outcomes in a multivariable 
context.
Objectives
The overall objective is to establish a prospective cohort of 
patients undergoing ARCR with standardised data collec-
tion and follow- up for the evaluation and prediction of 
targeted core safety, and clinical and patient- reported 
outcome parameters that are to be routinely collected in 
standard clinical care.
The primary objective is to develop predictive models 
for two core outcome parameters: (1) patient- reported 
Oxford Shoulder Score (OSS) functional outcome; and 
(2) occurrence of shoulder stiffness (primary safety 
event) as reported by patients and clinicians.
The secondary objectives are (1) to evaluate the content 
and applicability of the defined consensus CES (ie, ARCR 
CES 1.0)23 in routine practice considering the patient’s 
perspective; (2) to quantify the incidence of AE up to 24 
months after surgery (eg, persisting or worsening pain, 
recurrent rotator cuff defect); (3) to validate an adapted 
severity classification for postoperative local AEs12 36; and 
(4) to develop predictive models for other clinically rele-
vant outcome parameters, including patient- reported 
outcomes (eg, perception of improvement, return to 
work, return to sports, quality of life, satisfaction with 
surgery, acceptability of symptom state), clinical outcomes 
(eg, shoulder strength and motion) and specific AEs (eg, 
rotator cuff defect at 12 months).
METHODS AND ANALYSIS
Study design and setting
This is a prospective multicentre cohort study of patients 
undergoing ARCR with 17 participating orthopaedic 
centres in Switzerland and 1 German centre.
Several subprojects, associated with the main ARCR 
cohort study, are planned and include a systematic review 
of prognostic studies in ARCR, the application of the 
ARCR CES 1.0 for AE documentation, and the applica-
tion and validation of an AE severity classification.
Eligibility criteria
Adult patients diagnosed with a partial or full- thickness 
rotator cuff tear by MRI, planned for a primary 
arthroscopic surgical repair and giving their informed 
consent to participate in the cohort study will be included. 
Patients undergoing a specific surgical procedure for 
irreparable tears (ie, tendon transfer, subacromial spacer 
or superior capsular reconstruction), revision operations, 
and open or mini- open reconstructions will be excluded. 
Patients unable to provide written informed consent or 
attend clinics for follow- up visits, not fluent in German, 
French, Italian or English, or pregnant women will be 
excluded.
Patients undergoing bilateral ARCR will only be 
included for their first intervention.
Intervention
Shoulder arthroscopies will be performed according to 
standardised clinic- specific and international guidelines37 
in the context of routine care, with patients in a beach- 
chair or lateral decubitus position under general or local 
anaesthesia. The variability in the repair techniques used 
between clinics and surgeons will be documented. Typi-
cally, after the diagnostic arthroscopy to assess the type of 
rotator cuff tear (partial or full- thickness tear and involved 
tendons, tendon tear delamination, sign of tendon 
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degeneration) and concomitant injuries or lesions, the 
ruptured tendons are mobilised until they can be repo-
sitioned on the original footprint with as little tension as 
possible. Tendon fixation may be performed using one 
of multiple anchor and suture configurations according 
to the surgeon’s decision. An intervention at the biceps 
tendon is performed if any tendinopathy or lesions to the 
superior labrum or biceps pulley system are observed. An 
anterolateral or lateral acromioplasty is performed at the 
surgeon’s discretion, generally in the presence of a hook- 
shaped acromion or a critical shoulder angle larger than 
35°, respectively. Operative details, including additional 
concomitant procedures (acromioplasty, acromioclavic-
ular joint resection, capsulotomy, and biceps tenotomy 
or tenodesis) and duration of operation, are recorded 
immediately after surgery. A standard three- phase post-
operative rehabilitation scheme is usually prescribed and 
will be documented in detail, including immobilisation 
and passive mobilisation in the first phase, active mobil-
isation and coordination training in the second phase, 
followed by the third phase of specific progressive resis-
tance exercises.
Outcomes
The first primary outcome is the patient- reported change 
in shoulder functional outcome between baseline and 
6 months postoperatively as measured with the OSS.38 
The OSS is a condition- specific questionnaire developed 
for patients with a degenerative or inflammatory state 
of the shoulder. It contains 12 items to be answered by 
the patient independently, which deal with pain (degree, 
time point) and possible handicaps in private and profes-
sional life. There are five categories of response to every 
question, corresponding to a score ranging from 0 to 4. 
Scores are summed to give a single score ranging from 
0 (worst outcome) to 48 (best outcome). Transcultural 
validations of this questionnaire for the German and 
Italian populations have been performed39 40 and are 
validated for patient- based outcomes after rotator cuff 
repair.41–43 While functional outcome at the last 24- month 
follow- up is clinically relevant, the early 6- month primary 
time point is chosen because of the importance in early 
surgical recovery and rehabilitation, particularly when 
considering the socioeconomic impact on professionally 
active patients.4
The second primary outcome is the occurrence of shoulder 
stiffness within 6 months after surgery: this event is poorly 
defined in the literature.19 We formed a consensus defi-
nition of shoulder stiffness among specialised shoulder 
surgeons in a Delphi survey, which describes a postop-
erative restriction in passive shoulder motion diagnosed 
within 6 months after ARCR in at least two of the motion 
planes of flexion, abduction and external rotation in 0° 
abduction. Motion restriction is to be assessed separately 
for each plane according to specific threshold criteria 
(flexion: total motion equal to or below 90° or gleno-
humeral motion equal to or below 80°; abduction: total 
motion equal to or below 80° or glenohumeral motion 
equal to or below 60°; external rotation in 0° abduction: 
glenohumeral motion equal to or below 20° or no more 
than 50% of the contralateral side value). In this project, 
we will identify cases of shoulder stiffness based on our 
consensus definition as well as clinical records and reports 
from clinicians and their patients.
The secondary outcomes will include (1) local AEs 
according to the ARCR CES, in particular the occurrence 
of recurrent defect of repaired tendon(s) at 12 months, 
when at least one repaired tendon is diagnosed with a 
recurrent defect by ultrasound examination, persistent or 
worsening pain, infection, and any local event (composite 
outcome); (2) functional parameters of the Constant 
Score (CS)44 at 6 and 12 months, shoulder strength 
(kg) in abduction at 6 and 12 months, patient- reported 
shoulder pain on the Numeric Rating Scale (NRS) at 6, 
12 and 24 months, and patient- reported shoulder func-
tion: OSS at 6, 12 and 24 months, subjective shoulder 
value45 assessment at 6, 12 and 24 months; (3) general 
health and socioeconomic parameters including patient- 
reported quality of sleep (NRS) at 6, 12 and 24 months,46 
return to work, change of working condition within 6, 
12 and 24 months, level of depression and anxiety at 6, 
12 and 24 months based on Patient- Reported Outcomes 
Measurement Information System (PROMIS) scores,47 48 
patient- perceived shoulder improvement, acceptability 
of own symptom state,49 quality of life (utilities and 
general health) at 6, 12 and 24 months using the Euro-
pean Quality of Life 5 Dimensions 5 Level questionnaire 
(EQ- 5D- 5L), and patient satisfaction with the surgical 
outcome at 12 and 24 months; and (4) safety outcome 
assessment, occurrence of all AEs reported by clinicians 
and patients (including non- local AEs within 6 months 
after surgery), final independent surgeon and patient- 
rated assessment of AEs according to perceived severity 
(rating scale from 0 (no complication) to 100 (death)50), 
and Comprehensive Complication Index50 considering 
all AEs that occurred within 6 months after surgery.
Shoulder ultrasound examinations will be performed at 
12 months by experienced clinicians independent of the 
operating surgeons. The repair integrity will be graded 
according to an adaptation of the Sugaya classification 
(where, when using MRI images, grade 4 or 5 defines the 
occurrence of a recurrent effect).51 52 Other ultrasound 
parameters include the location of the recurrent defect 
(at the footprint/medial cuff failure), long biceps tendon 
status, signs of anchor displacement, and location and 
signs of suture cut- through.
Participant timeline
Local investigators will identify patients who meet the 
eligibility criteria. Patient enrolment started on 1 June 
2020 and is planned for a maximum period of 15 months. 
Patients will complete a preoperative evaluation no more 
than 2 months before surgery. Follow- up assessments will 
be performed at 6 weeks (±1 week) and at 6 (±1 month), 
12 (±1 month) and 24 (±2 months) months postoper-
atively. At the final 24- month time point, only patient 
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self- reporting assessments, including surveys on AEs, will 
be documented (figure 1). The end date for the study 
representing the collection of the last patient question-
naire is expected on 1 November 2023.
Baseline prognostic factors
Various baseline parameters, operative details and post-
operative management variables are known or suspected 
to influence ARCR outcomes.31–35
The following patient- related factors will be recorded: 
patient demographics (year of birth, age, sex), socioeco-
nomic parameters (nationality, marital status, highest level 
of education, employment status, last occupational posi-
tion, daily physical workload), dominant side, smoking 
and drinking status, general physical and mental health 
(body mass index and obesity), American Society of Anes-
thesiologists classification, comorbidities (eg, diabetes), 
concomitant medication, level of depression and anxiety 
(PROMIS Depression and Anxiety Short Form 4a),47 48 
and quality of life (EQ- 5D- 5L).53
Disease- related factors are shoulder clinical exam-
inations (pain level on NRS, range of motion, muscle 
strength, CS44), patient- reported shoulder function (see 
Outcomes section), radiograph parameters (critical 
shoulder angle,54 acromiohumeral distance55), MRI or 
arthro- CT parameters (supraspinatus muscle atrophy,56 
tangent sign,57 grade of fatty infiltration58 59) and medical 
history (cause of injury (trauma event), symptom dura-
tion, previous interventions (operation and timing of 
surgery), actual medication, extent of physical therapy).
Rotator cuff integrity and concomitant local findings will 
be investigated. The rotator cuff tear will be determined 
by MRI (or arthro- CT) and confirmed intraoperatively: 
tear size, location (involved tendons) and grading 
(partial/complete), tendon retraction grade60 and tear 
sagittal size,61 status of the biceps tendon, and additional 
intraoperative observation of concomitant local injuries 
(superior labrum from anterior to posterior (SLAP) 
lesion, humeral avulsion glenohumeral ligament, Bankart 
lesion, humeral and glenoid- side chondral lesions).
Operative details and postoperative management will 
also be investigated: type of ARCR procedure (use of 
anchors, suture techniques), augmentation techniques 
(eg, platelet concentrates, scaffolds and so on),62 addi-
tional concomitant treatment (acromioplasty, acromio-
clavicular joint resection, capsulotomy, biceps tenotomy 
or tenodesis, treatment of SLAP lesion), duration of 
operation, duration of hospital stay, and postoperative 
management (immobilisation position and duration, pain 
medication (eg, using non- steroidal anti- inflammatory 
drugs), timing of passive and active shoulder motion, and 
physiotherapy and muscle training).
AE documentation and assessment process
The operating surgeons will report the occurrence of 
any intraoperative AE on the operation form. The occur-
rence of postoperative local AEs within 24 months will 
be reported by investigators at the clinical examination 
and by patients on the questionnaires. The occurrence 
of postoperative non- local AEs that are unrelated to 
the operation will be documented in a similar manner, 
however only within 6 months after surgery. An AE form 
was developed according to the ARCR CES 1.0.23 Each 
AE documentation will be structured after Audigé et al63 
and includes the date/period of occurrence (intraoper-
ative/postoperative), the affected body location (local 
Figure 1 Flow chart of study procedures. AE survey: surgeon and patient survey regarding AE severity (sev). Motion: shoulder 
range of motion. Rehab: recall on postoperative rehabilitation. *If MRI not possible. AE, adverse event; CES, core event set; 
CS, Constant Score; CT, arthro- CT; DE, German; EN, English; EQ- 5D- 5L, European Quality of Life 5 Dimensions 5 Level 
questionnaire; FR, French; FU, follow- up; IT, Italian; NRS, Numeric Rating Scale; OSS, Oxford Shoulder Score; RC, rotator cuff; 
SSV, subjective shoulder value.
copyright.
 on A











pen: first published as 10.1136/bm





5Audigé L, et al. BMJ Open 2021;11:e045702. doi:10.1136/bmjopen-2020-045702
Open access
at the operated shoulder/non- local), the event group 
and specification, applied health- related intervention(s) 
(operative/non- operative procedure(s)), its outcome 
at the time of reporting (or end of the study), and the 
assessment of the event (causal factor(s)/severity grade/
seriousness). Severity grading will be made according to 
existing and adapted systems for intraoperative64 65 and 
postoperative12 36 complications.
The documentation of AEs will be checked for 
completeness and consistency remotely as well as on- site 
by reviewing selected patient files as part of the moni-
toring plan. A review committee (LA, AMM, TSt, HD 
and DS) will assess all events reported by surgeons and 
patients and generate queries to the respective sites as 
required.
Fully documented local events, including their treat-
ment, outcome and possible causative factors, will be 
formulated in layman’s terms and sent back to the 
affected patients so that they can confirm and validate 
collected AE data as well as assess their severity on a Visual 
Analogue Scale from 0 (not at all severe) to 100 (extremely 
severe). This subsequent rating will also be performed by 
their treating surgeon and four other randomly selected 
surgeons involved in the project, blinded to the original 
severity grading.
Sample size determination
For sample size calculation, we set up a simulation study 
and used multiple regression to predict the change in 
OSS within 6 months for the most important prognostic 
factors. The prognostic factors were derived from an 
existing ARCR local registry66 and include age, sex, body 
mass index/obesity status, tendon quality/degeneration 
and rotator cuff severity.31–35 We accounted for type I 
error at 5% for statistical significance and type II error 
set at 20% for 80% statistical power.67 Two thousand repli-
cations were done, and the p values were recorded to 
calculate the mean significance for each of the prognostic 
factors to reach a minimum of 80% statistical power. This 
approach led to a sample of 920 patients.
For the second primary outcome of shoulder stiffness, 
we accounted for a minimum of 10 events per variable 
to allow for the inclusion of a maximum of 10 predic-
tors into the model.68 69 The estimated event rate for 
shoulder stiffness from our pilot data set was 8.3%, which 
according to our experience might reflect an underesti-
mation of the true rate.17 Therefore, a 10% stiffness rate 
was assumed, which resulted in a sample size calculation 
of 900 patients.
The higher resulting number determines the final 
number of patients to be recruited. Therefore, 920 
patients will be included with an additional 50 patients (ie, 
970 patients) due to the anticipated maximum dropout 
rate of 5% at 6 months (based on personal experience).
Recruitment
Study sites and local investigators were selected based on 
their expertise in ARCR, with support from the shoulder 
and elbow expert group of Swiss Orthopaedics. Each site 
was visited by the project leaders to assess the adequacy 
of local clinical and research settings for the project as 
well as to ensure prior interest and commitment. The 
number of included sites was determined based on the 
reported estimate of the number of ARCR patients that 
could be realistically enrolled within 1 year from each 
site and included an allowance for overestimation (ie, all 
sites together estimated that they could recruit up to 40% 
more than the expected 970 patients within 1 year).
Patients who are enrolled after signing an informed 
consent form are definitively recruited for the project after 
documentation of baseline parameters (clinical examina-
tions and patient questionnaires) and confirmation of 
ARCR during surgery. A recruitment curve is prepared 
every 2 weeks and sent to the project sites along with a 
recruitment table presenting the performance of each 
site. Sites that are unable to recruit the expected number 
of patients within the first 3 months will be considered 
for exclusion from the project and replaced by additional 
sites if the estimated total duration of patient enrolment 
is delayed for more than 3 months.
Data collection methods
Data are collected on electronic or paper- based case 
report forms or patient questionnaires. Project parame-
ters and used instruments are presented in the previous 
sections of this protocol. A training video was prepared 
for the collection of CS data.44 For the measurement of 
shoulder muscle strength, several devices were permitted, 
that is, IsoForceControl (MDS Medical Device Solution, 
Oberburg, Switzerland), Mark-10 Force Gauge (Mark-10 
Corporation, Copiague, USA), as well as hand- held 
(Lafayette Instrument, Lafayette, USA) or MicroFET 2 
(Hoggan Scientific, Salt Lake City, USA) dynamometers; 
the use of a spring balance was not allowed.
Patient clinical examinations, including baseline 
imaging assessments, are performed at each site by expe-
rienced clinicians (who may be assisted by locally trained 
research staff) and documented primarily on paper- 
based case report forms. Baseline MRI and radiographs 
are coded and centralised at the University of Basel to 
ensure data quality control. Operative data are collected 
electronically by the respective surgeons shortly after 
surgery. Patients complete the questionnaires in their 
preferred language, which is limited to German, French, 
Italian or English, either electronically after invitation, by 
email or on a tablet computer at the site, or otherwise on 
paper. AEs are documented electronically by the respec-
tive surgeons with support from their research staff. Data 
collected on paper forms are entered electronically at 
each site or at a central location at the University of Basel 
based on the agreement made with each site.
Data monitoring
A central project data manager will perform data quality 
control on all collected data. A flow chart will be created 
to describe the number of consecutively recruited patients 
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who had a rotator cuff repair by arthroscopic procedure 
or had a conversion to an open procedure, and who 
completed follow- up clinical and imaging examinations 
as well as self- reported outcome questionnaires. The 
reasons for patient dropout and loss to follow- up status 
will be monitored and described. All recorded study 
parameters will be described using standard descrip-
tive statistics; continuous variables will be presented as 
means with SD and categorical variables as counts with 
percentages. The variability of data between clinics will 
be explored to support the identification of outlier data.
Weekly site- specific reports, including the patient enrol-
ment list, expected follow- up timing and identification of 
missing, erroneous or inconsistent data, are sent to the 
respective local project staff. Data- related queries will be 
resolved remotely or by on- site monitoring visits before 
the final analyses are performed.
There is no plan for auditing project conduct other 
than via reporting at the annual meetings of the project 
scientific board (PSB).
Data management
Study data will be stored using the REDCap web- based 
electronic data capture system70 71 on a server that is 
hosted at Schulthess Klinik. REDCap conforms with Good 
Clinical Practice guidelines, which provide the required 
features for data protection and integrity, for example, 
password- protected access and change tracking.
Study data will be coded and exported from the 
REDCap system into the Stata software version 16 for 
statistical analyses. Data transformations and analyses will 
be primarily implemented using Stata and fully docu-
mented within Stata programming files. Data subsets will 
be prepared for analyses using alternative software (eg, R 
for prediction models) as appropriate.
All patients with an intraoperatively confirmed rotator 
cuff tear and operated by ARCR will be included in the 
analyses. Existing missing data will be imputed if the 
number of missing data is non- negligible or could poten-
tially bias the results and conclusions.
Systematic review of prognostic factors
A systematic review of prognostic factors for ARCR 
outcomes is implemented (PROSPERO registration 
number: CRD42020199257). Briefly, literature from 2014 
to 2020 will be checked to identify longitudinal studies 
including patients diagnosed with a rotator cuff tear. 
These studies should report the effect of at least one 
factor on one of the following outcomes: shoulder stiff-
ness, rotator cuff tear repair integrity and shoulder func-
tion. Data extraction will follow a predefined template 
and the collected data will be stored within a separate 
database using REDCap. Data from different studies 
will be described and may be synthesised depending on 
the data type and heterogeneity. These data will be used 
to generate a list of factors most likely to influence our 
project outcomes and therefore should be considered for 
inclusion in the predictive model development process.
Predictive model development
To develop the predictive model(s), the seven steps 
proposed by Steyerberg et al72 73 will be used. The steps 
comprise (1) consideration of the research question and 
initial data inspection; (2) coding of the predictors; (3) 
model specification; (4) model estimation; (5) evaluation 
of model performance; (6) internal validation; and (7) 
model presentation.
Depending on the type of outcome, different models 
will be fitted and evaluated, that is, multiple regression 
models for the change in OSS at 6 months and multi-
variable logistic regression models for shoulder stiffness. 
Model diagnostics will be performed for all models to 
check the underlying assumptions.
The prediction of the model(s) will be based on the 
baseline, operative and postoperative management vari-
ables. First, a subset of the potential prognostic factors 
will be defined based on whether it is thought to be most 
predictive. The subset will be selected separately for each 
outcome by the Delphi method among the investiga-
tors, whereby the factors will be noted for their known 
or potential prognostic value on a 5- point Likert scale 
from 1 (not important) to 5 (extremely important). The 
factors with the highest mean score among investigators 
will form the subset.
We will then use criterion- based procedures (eg, Akaike 
information criterion or adjusted R2) to select the best set 
of predictors for the continuous outcome(s), and for the 
binary outcome we will use the area under the receiving 
operating characteristics curve.
To assess the predictive performance of the final models 
as well as the updated version of the prediction models, 
calibration plot and discrimination measures will be used. 
Thereby, apparent performance will be evaluated on 
the respective development data, and internal validated 
performance will be determined by bootstrapping. Inde-
pendent external validation will be estimated by applying 
the resulting models from the development data set in 
the respective validation data sets. The resulting models 
will be used to predict the change of outcome value (ie, 
OSS in 6 months) and assess whether a patient will expe-
rience the event (ie, shoulder stiffness).
If we observe missing data, then missing data imputa-
tion will be performed using a method that allows for 
uncertainty in the imputed values (eg, multiple imputa-
tions using chained equation74). We will account for the 
clustering of records within clinics as appropriate.
Adverse events
Occurring AEs other than those listed in the CES as well 
as events occurring outside the periods defined by the 
core set will be analysed separately for consideration of 
clinical relevance. This analysis will be made by the review 
committee and PSB comprising all local project leaders 
(principal investigators). Recommendations for change 
of the ARCR CES 1.0 by the PSB will be formulated.
The incidence of AEs, specific individual events and 
groups of events defined within the ARCR CES 1.0 up 
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to 24 months postoperatively will be displayed as the 
frequency of patients with an event relative to the number 
of patients observed, reported together with its 95% 
Wilson CI. These results will be presented in a summary 
table together with the absolute frequency. Further details 
on the period of occurrence will be given by stratifying for 
the time point of event occurrence. We will also stratify 
AEs according to their severity level and patient rele-
vance. Validation of the postoperative local AE severity 
classification system will be implemented using previously 
used methods.75 76
Patient and public involvement
No patient or member of the public was involved in the 
design of this cohort study protocol. Enrolled patients 
will contribute to the evaluation and validation of docu-
mented AEs and their severity grading, therefore to a 
potential revision of the ARCR CES. We are planning to 
present initial results to patients and the public and get 
feedback for further analyses and future model develop-
ment as well as documentation system in ARCR.
ETHICS AND DISSEMINATION
Research ethics approval
Ethical approval was obtained on 1 April 2020 from the 
lead ethics committee (EKNZ, Basel, Switzerland; ID: 
2019-02076).
Protocol amendments
Minor protocol amendments, for example, database 
production changes to facilitate monitoring processes or 
improve outcome assessment by questionnaire, are fully 
documented. Major amendments, for example, changes 
to the patient information sheet and consent form, 
change of a local project leader or the inclusion of a new 
project site, will be submitted for approval by the lead 
ethics committee as required.
Consent or assent
All participants will provide informed written consent 
prior to being enrolled into the study. The English 
version of the informed consent form used at the Univer-
sity Hospital of Basel is available as online supplemental 
file 1.
Confidentiality
Project data will be handled with utmost discretion and 
can only be accessed by authorised personnel as outlined 
by a study delegation list created for each project site. 
Patient data will be coded, that is, identified by a unique 
participant number. A participant identification list will 
be managed and kept in a place (an electronic folder or 
paper- based form) only accessible to authorised staff at 
each site.
The project leader affirms and upholds the principle of 
each patient’s right to privacy and that they shall comply 
with applicable privacy laws. In particular, anonymity of 
all patients shall be guaranteed when presenting the data 
at scientific meetings or publishing them in scientific 
journals.
Access to data
Project data will be shared at the end of the analysis 
process by the PSB. The Department of Clinical Research 
(German Departement Klinische Forschung, DKF) at 
the University Hospital of Basel will act as an indepen-
dent data access committee and will store the data at the 
time of publication on secure servers, maintained and 
backed up by the Information and Communication Tech-
nology Department at the University Hospital of Basel. 
Researchers who wish to reuse data will be able to submit 
a project synopsis to the DKF at  dkf. unibas. ch/ contact. A 
data- sharing statement referring researchers to the DKF 
for data access will be disseminated in the publications. 
Metadata describing the type, size and content of the data 
sets will be shared along with the study protocol on the 
Harvard Dataverse repository available online (https:// 
dataverse. harvard. edu/). Additionally, the case report 
forms will be uploaded on a medical data models portal 
(https:// medical- data- models. org/) and all variables will 
be annotated by their Unified Medical Language System 
Concept Unique Identifier to improve accessibility to 
other clinicians.
Dissemination policy
This project will lead to multiple open- access, peer- 
reviewed scientific publications, which will be prepared 
according to international standards (eg, the Strength-
ening the Reporting of Observational Studies in Epide-
miology statement77 for cohort studies; Transparent 
Reporting of a multivariable prediction model for Indi-
vidual Prognosis or Diagnosis78 statements for prognostic 
studies; Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses79 statement for systematic reviews). 
Publication authorship will be regulated according to the 
guidelines of the Swiss Academies of Arts and Sciences.80 
Results will be submitted for presentation at national 
and international conferences. In addition, lay summary 
results will be developed and made available for patients 
and the public.
Scientific relevance and broader impact
This project initiates the development of personalised 
risk predictions to support the surgical decision process 
in ARCR. The consensus CES may become an interna-
tional reference for the reporting of complications in 
clinical studies and registries, and may therefore provide 
a solid metric for the documentation of surgical safety in 
ARCR. Methodological insight gained from this project 
will be easily transferable to similar initiatives and thus 
may foster the realisation of other cohorts on safety and 
effectiveness outcome in shoulder surgery (eg, arthro-
plasty) and orthopaedics in general.
For patients affected by rotator cuff tears and their 
surgeons, this study will be the first to provide solid data 
on the incidence of patient- validated AEs and other core 
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outcomes up to 2 years after surgical repair based on 
international consensus COS and CES. This study will 
allow the investigation of a comprehensive list of poten-
tial prognostic factors to generate predictive models for 
these core outcomes and hence offer personalised health 
information to support future patients and surgeons in 
the decision process for surgery. Outcome predictors 
and risk calculators are increasingly being developed in 
numerous medical fields including surgery and orthopae-
dics, and they are in development in the field of ARCR.
This study will assess the structure and content of 
the ARCR CES and consolidate its validity in capturing 
unfavourable events of importance to both patients 
and surgeons; considering the patient’s perspective is 
an essential step in the development of a COS. Further-
more, the validation of an adapted severity classification 
of AEs in this study will provide an essential system for 
assessing surgical morbidity in orthopaedics. We expect 
that the ARCR CES and the event severity classification 
will become international standards for the reporting of 
ARCR AEs in clinical studies and registries, and therefore 
provide a solid metric for the documentation of surgical 
safety in ARCR.
This study fosters the enterprise in developing a Swiss- 
wide registry of ARCR, which will allow the ongoing eval-
uation and prediction of targeted core safety and clinical 
and patient- reported outcomes. The identification of 
factors mostly associated with relevant outcomes will facil-
itate a lean and straightforward documentation process 
for ARCR patients in Switzerland and abroad.
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